Drug Trial Radar · NCT03425396
Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis
Last checked: Nov 20, 2026Latest source record: Jun 9, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
225
Actual
Start
Jan 4, 2018
Primary completion
May 15, 2019
Study completion Jun 5, 2019
Sponsor
- Lead sponsor
- Paratek Pharmaceuticals IncIndustry
- Sponsor type
- Industry
- First posted
- Feb 7, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of oral omadacycline as compared to oral nitrofurantoin in the treatment of female adults with cystitis.
Conditions
- Uncomplicated Urinary Tract Infection
- Cystitis
Interventions
Omadacycline tabletsDrug
Oral Omadacycline
Nitrofurantoin capsulesDrug
Oral Nitrofurantoin
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With an Investigator Assessment of Clinical Response at the Post Therapy Evaluation (PTE) Visit (ITT Population)Time frame: Day 14 (A PTE occurred on Day 14 ± 2 days after the participant's first dose of study drug)
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Site 106
Chula Vista, California
Site 101
La Mesa, California
Site 109
Los Angeles, California
Site 114
Aventura, Florida
Site 102
DeLand, Florida
Site 103
Hialeah, Florida
Site 125
Jacksonville, Florida
Site 121
Miami, Florida
Site 130
Miami, Florida
Site 115
Miami, Florida
Site 127
Miami Springs, Florida
Site 126
Orlando, Florida
Site 113
Newton, Kansas
Site 110
Wichita, Kansas
Site 112
Omaha, Nebraska
Site 132
Las Vegas, Nevada
Site 108
Las Vegas, Nevada
Site 122
Berlin, New Jersey
Site 118
Raleigh, North Carolina
Site 104
Jackson, Tennessee
Site 105
Smyrna, Tennessee
Site 131
Houston, Texas
Site 120
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.